BIN1-dependent trafficking defects determine whether post-Aβ tau missorting resolves or persists

Target: BIN1,MAPT Composite Score: 0.460 Price: $0.46 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
C
Composite: 0.460
Top 82% of 1222 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 78%
D Evidence Strength 15% 0.39 Top 87%
B Novelty 12% 0.63 Top 76%
B Feasibility 12% 0.64 Top 43%
D Impact 12% 0.34 Top 98%
F Druggability 10% 0.24 Top 95%
C+ Safety Profile 8% 0.52 Top 56%
C+ Competition 6% 0.51 Top 83%
D Data Availability 5% 0.39 Top 92%
C Reproducibility 5% 0.40 Top 86%
Evidence
1 supporting | 2 opposing
Citation quality: 0%
Debates
1 session B
Avg quality: 0.65
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration?

The debate proposed that Aβ-induced tau missorting creates self-sustaining toxicity, but didn't resolve whether this state is truly Aβ-independent once established. This is critical for understanding why anti-Aβ therapies fail and whether tau-targeting must follow specific temporal windows. Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-180503-a7a03974_20260416-134419 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-180503-a7a03974)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Tau missorting transitions into an autonomous tau-seeding state after transient Aβ exposure
Score: 0.740 | Target: MAPT
Microglia and complement sustain post-Aβ neurodegeneration after tau missorting is established
Score: 0.690 | Target: C1QA,C1QB,C1QC,C3,ITGAM,TREM2,TYROBP
Fyn-anchored dendritic tau/NMDAR signaling persists after transient Aβ exposure
Score: 0.670 | Target: MAPT,FYN,DLG4,GRIN2B
A post-trigger CDK5-dominant kinase feedback loop maintains dendritic phospho-tau missorting
Score: 0.590 | Target: MAPT,CDK5,CAPN1,GSK3B
Dendritic tau missorting persists through local proteostatic failure in endolysosomal and autophagy pathways
Score: 0.530 | Target: MAPT,RAB5,RAB7,LAMP1,TFEB
Reactive astrocyte glutamate-handling failure sustains dendritic tau-associated excitotoxic stress after Aβ clearance
Score: 0.490 | Target: SLC1A2,GRIN2B,MAPT

→ View full analysis & all 7 hypotheses

Description

Aβ initially perturbs tau localization, but persistence depends on BIN1-regulated membrane and endocytic trafficking that prevents tau re-entry into the axon and stabilizes dendritic retention. This is a useful genetic-modifier hypothesis, but currently the least supported as a primary mechanism.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.39 (15%) Novelty 0.63 (12%) Feasibility 0.64 (12%) Impact 0.34 (12%) Druggability 0.24 (10%) Safety 0.52 (8%) Competition 0.51 (6%) Data Avail. 0.39 (5%) Reproducible 0.40 (5%) 0.460 composite
3 citations 3 with PMID Validation: 0% 1 supporting / 2 opposing
For (1)
No supporting evidence
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
1
MECH 2CLIN 0GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
BIN1 is a strong AD risk locus with links to tau b…SupportingGENE----PMID:29479533-
The BIN1-tau relationship is complex and not strai…OpposingMECH----PMID:29479533-
Isoform- and cell-type-specific BIN1 biology makes…OpposingMECH----PMID:29479533-
Legacy Card View — expandable citation cards

Supporting Evidence 1

BIN1 is a strong AD risk locus with links to tau biology and trafficking, supporting modifier-level relevance.

Opposing Evidence 2

The BIN1-tau relationship is complex and not straightforward, with sparse evidence that BIN1 controls post-Aβ …
The BIN1-tau relationship is complex and not straightforward, with sparse evidence that BIN1 controls post-Aβ persistence of missorting specifically.
Isoform- and cell-type-specific BIN1 biology makes simple causal interpretations in iPSC neurons uncertain.
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-25 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

  • Title: Fyn-anchored dendritic tau becomes self-sustaining after transient Aβ exposure
  • Mechanism: Aβ oligomers drive tau missorting from axon to dendritic spines, where tau binds FYN and stabilizes an NMDA receptor-associated excitotoxic signaling complex. Once established, this tau-Fyn-PSD95/NMDAR scaffold may persist without continued Aβ, maintaining calcium dysregulation, spine loss, and downstream degeneration. Target gene/protein/pathway: MAPT (tau), FYN, PSD95/DLG4, NMDAR/SRC-family signaling Supporting evidence: Strong prior literature links dendritic tau

    🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

    Below the central skeptical point applies to all seven: current literature strongly supports that Aβ can induce dendritic/somatodendritic tau missorting and synaptic toxicity, but it does not cleanly establish that the state becomes truly Aβ-independent after complete Aβ removal. Most cited evidence is either acute Aβ exposure, constitutive transgenic overexpression, or end-stage human tissue, which cannot separate “self-sustaining tau pathology” from “residual upstream injury,” incomplete Aβ clearance, or generic degeneration.

  • **Fyn-anchored dendritic tau self-sustains after transient
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    Most investable survivors are `6 > 4 > 1 > 2`. I would not spend serious translational budget yet on `7`, and I would treat `3` and `5` as modifier mechanisms rather than lead programs.

    | Rank | Hypothesis | Druggability | Biomarkers | Best model systems | Safety / translational risk | Realistic path |
    |---|---|---|---|---|---|---|
    | 1 | `6` Tau missorting transitions into autonomous tau seeding | High, relative to others. Clear intervention classes: anti-tau antibodies, seed-blocking biologics, ASOs, uptake blockers. | CSF/plasma p-tau217, p-tau181, MTBR-tau, tau seeding assays, tau PET, syn

    Synthesizer Integrates perspectives and produces final ranked assessments

    {"ranked_hypotheses":[{"title":"Tau missorting transitions into an autonomous tau-seeding state after transient Aβ exposure","description":"Transient Aβ exposure induces dendritic tau missorting that then converts into a locally self-propagating tau oligomer/seeding program. After verified Aβ clearance, continued degeneration is driven by tau seed formation, templated misfolding, and trans-synaptic spread rather than by ongoing amyloid signaling.","target_gene":"MAPT","dimension_scores":{"evidence_strength":0.78,"novelty":0.72,"feasibility":0.83,"therapeutic_potential":0.84,"mechanistic_plausi

    Price History

    No price history recorded yet

    7d Trend
    Stable
    7d Momentum
    ▲ 0.0%
    Volatility
    Low
    0.0000
    Events (7d)
    0

    Clinical Trials (0)

    No clinical trials data available

    📚 Cited Papers (1)

    Paper:29479533
    No extracted figures yet

    📓 Linked Notebooks (0)

    No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    Related Hypotheses

    TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
    Score: 0.990 | neurodegeneration
    TREM2-Dependent Microglial Senescence Transition
    Score: 0.950 | neurodegeneration
    PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction
    Score: 0.941 | neurodegeneration
    Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Prediction
    Score: 0.933 | neurodegeneration
    CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
    Score: 0.921 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions

    No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

    Knowledge Subgraph (0 edges)

    No knowledge graph edges recorded

    3D Protein Structure

    🧬 BIN1 — Search for structure Click to search RCSB PDB
    🔍 Searching RCSB PDB for BIN1 structures...
    Querying Protein Data Bank API

    Source Analysis

    Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration?

    neurodegeneration | 2026-04-25 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)